MSDL

MSDL is an externally-managed business development company whose stock screens cheap on the surface: at $15.64 against book equity of $1.75B over 85.6M shares (~$20.44 NAV/share), it trades at roughly 0.77x NAV — a ~23% discount unusual for a Morgan Stanley-sponsored lender — and carries a P/E of 11.2 on $1.40 diluted EPS. The $2.00/share of regular 2025 distributions equates to a ~12.8% yield on price, and management is leaning into the discount, repurchasing shares below NAV (buyback cash up 132% to $42M, executed at $18-20 vs a ~$20 NAV) which is accretive to remaining holders. The balance sheet is unremarkable but not stressed: liabilities/equity of 1.24x is conservative for a BDC, operating cash flow more than doubled to $151M, and the auditor issued an unqualified opinion on both the financials and internal controls.

The problem is earnings quality and direction. Net income fell 43% to $122M and EPS fell 42% to $1.40, while the fund paid $184M of dividends — distributions ran well ahead of GAAP earnings, which is why stockholders' equity slipped 5.1% and retained earnings turned negative (-$19.6M). A payout that exceeds earnings is, by definition, eroding NAV, and the very discount that looks like a bargain is partly the market pricing in that erosion plus credit risk in a private-credit portfolio. The MD&A confirms the 2024 distribution already stepped down from $2.20 to $2.00, so the trend is the wrong way.